Left ventricular remodeling after primary percutaneous coronary intervention
Guido Parodi1, David Antoniucci
1Division of Cardiology, Careggi Hospital, Florence, Italy. parodiguido@gmail.com
American Heart Journal
|December 15, 2010
Summary
Left ventricular remodeling after heart attack treatment increases mortality. Early intervention is crucial to prevent or limit this remodeling and improve patient survival.
Area of Science:
- Cardiology
- Cardiovascular Research
- Medical Diagnostics
Background:
- Left ventricular (LV) remodeling occurs in a significant number of patients post-acute myocardial infarction despite successful primary percutaneous coronary intervention.
- LV remodeling is linked to increased mortality and reduced event-free survival.
- Therapeutic strategies to prevent or mitigate LV remodeling are critical, particularly in the early reperfusion phase.
Purpose of the Study:
- To discuss the pathophysiology, temporal progression, and predictive factors of LV remodeling.
- To review current diagnostic techniques for identifying LV remodeling.
- To evaluate therapeutic interventions aimed at managing LV remodeling.
Main Methods:
- Review of existing literature on LV remodeling post-primary percutaneous coronary intervention.
- Analysis of studies focusing on the time course and predictors of LV remodeling.
- Examination of diagnostic modalities and therapeutic strategies.
Main Results:
- LV remodeling is a common complication following successful primary percutaneous coronary intervention for acute myocardial infarction.
- The presence and extent of LV remodeling correlate with adverse clinical outcomes, including mortality.
- Early identification of patients at risk is essential for prognostic and therapeutic considerations.
Conclusions:
- Preventing or limiting LV remodeling is a key therapeutic goal in acute myocardial infarction management.
- Early therapeutic interventions initiated during the reperfusion phase are paramount.
- Understanding the predictors and diagnostic markers of LV remodeling can guide risk stratification and treatment decisions.
Related Concept Videos
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


